TxCell launches a capital increase

Teaching regulatory T cells to treat your disease

TxCell develops unique cellular immunotherapy platforms based on antigen-specific regulatory T cells for the treatment of severe autoimmune and inflammatory diseases as well as transplantation-related inflammatory disorders

News
More…
Highlights